홈 › 만성 폐쇄성 폐질환 › 플로리다
플로리다의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 28개가 플로리다 내 여러 지역에서 참여자를 모집하고 있습니다.
플로리다의 도시
- Miami연구 18개
- Orlando연구 15개
- Hialeah연구 8개
- Kendall연구 7개
- Tampa연구 7개
- West Palm Beach연구 6개
- Jacksonville연구 5개
- Ocala연구 5개
- Boca Raton연구 4개
- Doral연구 4개
- Deltona연구 3개
- St. Petersburg연구 3개
- Clearwater연구 3개
- Palm Coast연구 3개
- Naples연구 3개
- Cape Coral연구 3개
- Plantation연구 3개
공식 연구 텍스트(영어)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07780656A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
피험자 모집 중2상
40세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
피험자 모집 중4상
40세 ~ 85세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- 외 10개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
피험자 모집 중
40세 ~ 80세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
피험자 모집 중2상
40세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- Direct Helpers Research Center- Site Number : 8400057, Hialeah
- Pulmonary Specialists of the Palm Beaches- Site Number : 8400017, Loxahatchee Groves
- 외 10개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07190222A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- 외 17개
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- 외 5개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- 외 9개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- 외 9개
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
피험자 모집 중2상
18세 ~ 85세 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07705737A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- 외 25개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06283966Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- 외 2개
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT07684820STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- 외 8개
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
피험자 모집 중
18세 ~ 100세 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
피험자 모집 중
40세 ~ 80세 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
피험자 모집 중
40세 ~ 84세 · 모든 성별 · 2026. 4. 24. 업데이트됨 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- 외 15개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2025. 10. 8. 업데이트됨 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- 외 3개
피험자 모집 중관찰 연구
50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- 외 2개
피험자 모집 중
30세 이상 · 모든 성별 · 2025. 2. 6. 업데이트됨 · NCT05204888ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.